Strategies for the Management of Spike Protein-Related Pathology
In the wake of the COVID-19 crisis, a need has arisen to prevent and treat two related conditions, COVID-19 vaccine injury and long COVID-19, both of which can trace at least part of their aetiology to the spike protein, which can cause harm through several mechanisms. One significant mechanism of h...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-05-01
|
| Series: | Microorganisms |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-2607/11/5/1308 |
| _version_ | 1797598968459296768 |
|---|---|
| author | Matthew T. J. Halma Christof Plothe Paul Marik Theresa A. Lawrie |
| author_facet | Matthew T. J. Halma Christof Plothe Paul Marik Theresa A. Lawrie |
| author_sort | Matthew T. J. Halma |
| collection | DOAJ |
| description | In the wake of the COVID-19 crisis, a need has arisen to prevent and treat two related conditions, COVID-19 vaccine injury and long COVID-19, both of which can trace at least part of their aetiology to the spike protein, which can cause harm through several mechanisms. One significant mechanism of harm is vascular, and it is mediated by the spike protein, a common element of the COVID-19 illness, and it is related to receiving a COVID-19 vaccine. Given the significant number of people experiencing these two related conditions, it is imperative to develop treatment protocols, as well as to consider the diversity of people experiencing long COVID-19 and vaccine injury. This review summarizes the known treatment options for long COVID-19 and vaccine injury, their mechanisms, and their evidentiary basis. |
| first_indexed | 2024-03-11T03:28:06Z |
| format | Article |
| id | doaj.art-23ac2209772748dfa8014b342c54e70c |
| institution | Directory Open Access Journal |
| issn | 2076-2607 |
| language | English |
| last_indexed | 2024-03-11T03:28:06Z |
| publishDate | 2023-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Microorganisms |
| spelling | doaj.art-23ac2209772748dfa8014b342c54e70c2023-11-18T02:34:51ZengMDPI AGMicroorganisms2076-26072023-05-01115130810.3390/microorganisms11051308Strategies for the Management of Spike Protein-Related PathologyMatthew T. J. Halma0Christof Plothe1Paul Marik2Theresa A. Lawrie3EbMCsquared CIC, 11 Laura Place, Bath BA2 4BL, UKCenter for Biophysical Osteopathy, Am Wegweiser 27, 55232 Alzey, GermanyFront Line COVID-19 Critical Care Alliance (FLCCC), 2001 L St. NW Suite 500, Washington, DC 20036, USAEbMCsquared CIC, 11 Laura Place, Bath BA2 4BL, UKIn the wake of the COVID-19 crisis, a need has arisen to prevent and treat two related conditions, COVID-19 vaccine injury and long COVID-19, both of which can trace at least part of their aetiology to the spike protein, which can cause harm through several mechanisms. One significant mechanism of harm is vascular, and it is mediated by the spike protein, a common element of the COVID-19 illness, and it is related to receiving a COVID-19 vaccine. Given the significant number of people experiencing these two related conditions, it is imperative to develop treatment protocols, as well as to consider the diversity of people experiencing long COVID-19 and vaccine injury. This review summarizes the known treatment options for long COVID-19 and vaccine injury, their mechanisms, and their evidentiary basis.https://www.mdpi.com/2076-2607/11/5/1308long COVIDCOVID-19 vaccine injuryspike proteinthrombosisinflammationrepurposed medication |
| spellingShingle | Matthew T. J. Halma Christof Plothe Paul Marik Theresa A. Lawrie Strategies for the Management of Spike Protein-Related Pathology Microorganisms long COVID COVID-19 vaccine injury spike protein thrombosis inflammation repurposed medication |
| title | Strategies for the Management of Spike Protein-Related Pathology |
| title_full | Strategies for the Management of Spike Protein-Related Pathology |
| title_fullStr | Strategies for the Management of Spike Protein-Related Pathology |
| title_full_unstemmed | Strategies for the Management of Spike Protein-Related Pathology |
| title_short | Strategies for the Management of Spike Protein-Related Pathology |
| title_sort | strategies for the management of spike protein related pathology |
| topic | long COVID COVID-19 vaccine injury spike protein thrombosis inflammation repurposed medication |
| url | https://www.mdpi.com/2076-2607/11/5/1308 |
| work_keys_str_mv | AT matthewtjhalma strategiesforthemanagementofspikeproteinrelatedpathology AT christofplothe strategiesforthemanagementofspikeproteinrelatedpathology AT paulmarik strategiesforthemanagementofspikeproteinrelatedpathology AT theresaalawrie strategiesforthemanagementofspikeproteinrelatedpathology |